Sax Wealth Advisors’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.32M Buy
2,354
+1,163
+98% +$652K 0.05% 193
2026
Q1
$806K Sell
1,191
-350
-23% -$224K 0.04% 222
2025
Q4
$1.04M Sell
1,541
-13
-0.8% -$8.85K 0.05% 196
2025
Q3
$993K Buy
1,554
+26
+2% +$15.8K 0.05% 187
2025
Q2
$820K Buy
1,528
+158
+12% +$75.6K 0.05% 193
2025
Q1
$575K Sell
1,370
-56
-4% -$24.3K 0.04% 200
2024
Q4
$590K Buy
1,426
+617
+76% +$271K 0.05% 174
2024
Q3
$409K Sell
809
-212
-21% -$103K 0.04% 179
2024
Q2
$497K Buy
+1,021
New +$513K 0.05% 144

Other funds holding IDXX

Sax Wealth Advisors's IDXX Position: Q2 2026 in Review

Sax Wealth Advisors increased its Idexx Laboratories (IDXX) stake by 98% in Q2 2026, buying an estimated $652K and bringing the position to 2,354 shares worth $1.32M. The position accounts for 0.05% of the portfolio, ranked #193.

Sax Wealth Advisors first reported a position in IDXX in Q2 2024 and has held it in 9 quarters since. 238 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Sax Wealth Advisors held 2,354 shares of Idexx Laboratories worth $1.32M as of Q2 2026.
  • Sax Wealth Advisors bought 1,163 Idexx Laboratories shares in Q2 2026, an estimated $652K.
  • Idexx Laboratories made up 0.05% of Sax Wealth Advisors's portfolio in Q2 2026, its #193 holding.
  • Sax Wealth Advisors first reported a position in Idexx Laboratories in Q2 2024 and has held it in 9 quarters since.
  • 238 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Sax Wealth Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.